Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone

被引：32

作者：

Cruciani, RA ^{[1
]}

Lussier, D

Miller-Saultz, D

Arbuck, DM

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA

[2] Meridian Hlth Grp, Carmel, IN USA

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2003年 / 25卷 / 06期

关键词：

D O I：

10.1016/S0885-3924(03)00139-8

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：491 / 494

页数：4

共 11 条

[1]

CEPEDA MS, 2002, PAIN, P1

[2] OPIOIDS CAN EVOKE DIRECT RECEPTOR-MEDIATED EXCITATORY EFFECTS ON SENSORY NEURONS [J].

CRAIN, SM ;

SHEN, KF .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (02) :77-81

[3] Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability [J].

Crain, SM ;

Shen, KF .

PAIN, 2000, 84 (2-3) :121-131

[4]

Cruciani R. A., 1999, Society for Neuroscience Abstracts, V25, P1478

[5]

CRUCIANI RA, 2000, P INT NARC RES C, V59

[6] THE NMDA RECEPTOR ANTAGONISTS, LY274614 AND MK-801, AND THE NITRIC-OXIDE SYNTHASE INHIBITOR, NG-NITRO-L-ARGININE, ATTENUATE ANALGESIC TOLERANCE TO THE MU-OPIOID MORPHINE BUT NOT TO KAPPA-OPIOIDS [J].

ELLIOTT, K ;

MINAMI, N ;

KOLESNIKOV, YA ;

PASTERNAK, GW ;

INTURRISI, CE .

PAIN, 1994, 56 (01) :69-75

[7] Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate [J].

Gan, TJ ;

Ginsberg, B ;

Glass, PSA ;

Fortney, J ;

Jhaveri, R ;

Perno, R .

ANESTHESIOLOGY, 1997, 87 (05) :1075-1081

[8] Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats [J].

Mao, JR ;

Price, DD ;

Caruso, FS ;

Mayer, DJ .

PAIN, 1996, 67 (2-3) :361-368

[9] Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X [J].

Pan, YX ;

Xu, J ;

Mahurter, L ;

Xu, MM ;

Gilbert, AK ;

Pasternak, GW .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (04) :1057-1061

[10]

Sang CN, 2000, J PAIN SYMPTOM MANAG, V19, pS21

← 1 2 →